148 related articles for article (PubMed ID: 15983961)
21. Valve replacement surgery in patients with end-stage renal disease: long-term results.
Gultekin B; Ozkan S; Uguz E; Atalay H; Akay T; Arslan A; Sezgin A; Ozdemir N; Tasdelen A; Aslamaci S
Artif Organs; 2005 Dec; 29(12):972-5. PubMed ID: 16305653
[TBL] [Abstract][Full Text] [Related]
22. Endothelial injury is closely related to osteopontin and TNF receptor-mediated inflammation in end-stage renal disease.
Batko K; Krzanowski M; Gajda M; Dumnicka P; Fedak D; Woziwodzka K; Sułowicz W; Kuźniewski M; Litwin JA; Krzanowska K
Cytokine; 2019 Sep; 121():154729. PubMed ID: 31153055
[TBL] [Abstract][Full Text] [Related]
23. Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.
Takahashi H; Ishii H; Aoyama T; Kamoi D; Kasuga H; Ito Y; Yasuda K; Tanaka M; Yoshikawa D; Maruyama S; Matsuo S; Murohara T; Yuzawa Y
Am J Kidney Dis; 2013 Feb; 61(2):254-61. PubMed ID: 23122492
[TBL] [Abstract][Full Text] [Related]
24. Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation.
Pohjolainen V; Taskinen P; Soini Y; Rysä J; Ilves M; Juvonen T; Ruskoaho H; Leskinen H; Satta J
Hum Pathol; 2008 Nov; 39(11):1695-701. PubMed ID: 18701137
[TBL] [Abstract][Full Text] [Related]
25. Heart valve replacement for patients with end-stage renal disease in Japan.
Misawa Y
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):4-8. PubMed ID: 20190702
[TBL] [Abstract][Full Text] [Related]
26. Doppler echocardiographic assessment of valvular heart disease in patients requiring hemodialysis for end-stage renal disease.
Stinebaugh J; Lavie CJ; Milani RV; Cassidy MM; Figueroa JE
South Med J; 1995 Jan; 88(1):65-71. PubMed ID: 7817230
[TBL] [Abstract][Full Text] [Related]
27. Soluble osteopontin and vascular calcification in hemodialysis patients.
Nitta K; Ishizuka T; Horita S; Hayashi T; Ajiro A; Uchida K; Honda K; Oba T; Kawashima A; Yumura W; Kabaya T; Akiba T; Nihei H
Nephron; 2001 Dec; 89(4):455-8. PubMed ID: 11721165
[TBL] [Abstract][Full Text] [Related]
28. Ectopic calcification: new concepts in cellular regulation.
Giachelli CM
Z Kardiol; 2001; 90 Suppl 3():31-7. PubMed ID: 11374030
[TBL] [Abstract][Full Text] [Related]
29. Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease.
Cadavid JC; DiVietro ML; Torres EA; Fumo P; Eiger G
Chest; 2011 Jun; 139(6):1503-1506. PubMed ID: 21652561
[TBL] [Abstract][Full Text] [Related]
30. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
31. Icodextrin eliminates phosphate and ameliorates cardiac hypertrophy and valvular calcification in patients with end-stage renal disease and diabetes mellitus undergoing peritoneal dialysis.
Hiramatsu T; Hayasaki T; Hobo A; Furuta S; Kabu K; Tonozuka Y; Iida Y
Adv Perit Dial; 2013; 29():9-13. PubMed ID: 24344483
[TBL] [Abstract][Full Text] [Related]
32. [Comparative study on the sclerotic changes of cardiac valve and blood vessel].
Togashi M; Tamura K; Madenokouji N; Fukuda Y; Sugisaki Y
J Nippon Med Sch; 2003 Dec; 70(6):496-508. PubMed ID: 14685290
[TBL] [Abstract][Full Text] [Related]
33. Periaortic Fat Tissue: A Predictor of Cardiac Valvular Calcification, Malnutrition, Inflammation, and Atherosclerosis Components in Hemodialysis Patients.
Genctoy G; Eldem O; Ergun T; Arikan S
Artif Organs; 2015 Sep; 39(9):748-55. PubMed ID: 25940595
[TBL] [Abstract][Full Text] [Related]
34. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease.
Sharma R; Pellerin D; Gaze DC; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
Atherosclerosis; 2007 Apr; 191(2):348-54. PubMed ID: 16647710
[TBL] [Abstract][Full Text] [Related]
35. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
[TBL] [Abstract][Full Text] [Related]
36. Vascular calcification in dialysis patients: pathogenesis and consequences.
Reslerova M; Moe SM
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
[TBL] [Abstract][Full Text] [Related]
37. Morphological and clinical findings in 247 surgically excised native aortic valves.
Butany J; Collins MJ; Demellawy DE; Nair V; Israel N; Leong SW; Borger MA
Can J Cardiol; 2005 Jul; 21(9):747-55. PubMed ID: 16082434
[TBL] [Abstract][Full Text] [Related]
38. Valve Selection in End-Stage Renal Disease: Should It Always Be Biological?
Williams ML; Bavaria JE; Acker MA; Desai ND; Vallabhajosyula P; Hargrove WC; Atluri P; Szeto WY
Ann Thorac Surg; 2016 Nov; 102(5):1531-1535. PubMed ID: 27544289
[TBL] [Abstract][Full Text] [Related]
39. Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Raggi P; Bommer J; Chertow GM
J Heart Valve Dis; 2004 Jan; 13(1):134-41. PubMed ID: 14765851
[TBL] [Abstract][Full Text] [Related]
40. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.
Wada T; McKee MD; Steitz S; Giachelli CM
Circ Res; 1999 Feb; 84(2):166-78. PubMed ID: 9933248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
